Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
444,806,861
-
Total 13F shares
-
1,274,256
-
Share change
-
+1,199,256
-
Total reported value
-
$1,096,621
-
Price per share
-
$0.86
-
Number of holders
-
26
-
Value change
-
+$1,015,621
-
Number of buys
-
23
-
Number of sells
-
1
Institutional Holders of PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) as of Q2 2014
As of 30 Jun 2014,
PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,274,256 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, UBS AG, Knoll Capital Management, LP, KCG Holdings, Inc., Commonwealth Equity Services, Inc, LPL Financial LLC, Creative Planning, AMERICAN INTERNATIONAL GROUP INC, HUDSON CANYON INVESTMENT COUNSELORS LLC, and National Asset Management, Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.